½ÃÀ庸°í¼­
»óǰÄÚµå
1476438

¼®°í ¹× ºÎ¸ñ ½ÃÀå ¿¹Ãø(-2030³â) : Á¦Ç° À¯Çü, ¿ëµµ, ÃÖÁ¾»ç¿ëÀÚ, Áö¿ªº° ¼¼°è ºÐ¼®

Casting and Splinting Market Forecasts to 2030 - Global Analysis By Product Type (Casting and Splinting), Application, End User and By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Stratistics Market Research Consulting | ÆäÀÌÁö Á¤º¸: ¿µ¹® 200+ Pages | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    



¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

Stratistics MRC¿¡ µû¸£¸é, ¼®°í ¹× ºÎ¸ñ ¼¼°è ½ÃÀåÀº 2023³â 28¾ï ´Þ·¯ ±Ô¸ðÀ̸ç, ¿¹Ãø ±â°£ µ¿¾È 8.7%ÀÇ CAGR·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 51¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼®°í ¹× ºÎ¸ñÀº ºÎ»ó´çÇÑ »À¿Í ¿¬Á¶Á÷À» °íÁ¤Çϰí ÁöÁöÇÏ´Â µ¥ »ç¿ëµÇ´Â Á¤Çü¿Ü°ú ±â¼úÀÔ´Ï´Ù. ¼®°í´Â ÀϹÝÀûÀ¸·Î À¯¸®¼¶À¯ ¶Ç´Â ¼®°í·Î ¸¸µé¾îÁ® ºÎ»ó ºÎÀ§¸¦ ¿ÏÀüÈ÷ °¨½Î°í ´Ü´ÜÈ÷ ¾ÈÁ¤È­½Ãŵ´Ï´Ù. ºÎ¸ñÀº ±Ý¼ÓÀ̳ª À¯¸®¼¶À¯¿Í °°Àº Àç·á·Î ¸¸µé¾îÁ® ´õ À¯¿¬Çϸç ÀϽÃÀûÀÎ Áö¿øÀ̳ª °æ¹ÌÇÑ °ñÀý¿¡ ÀÚÁÖ »ç¿ëµË´Ï´Ù. µÎ °¡Áö ¹æ¹ý ¸ðµÎ Ä¡À¯¸¦ ÃËÁøÇϰí ÅëÁõÀ» ¿ÏÈ­ÇÏ¸ç ¿òÁ÷ÀÓÀ» Á¦ÇÑÇÏ¿© Ãß°¡ ¼Õ»óÀ» ¹æÁöÇÏ´Â °ÍÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ÈÆ·ÃµÈ Àü¹®°¡¿¡ ÀÇÇÑ ÀûÀýÇÑ Âø¿ëÀº È¿°ú¸¦ º¸ÀåÇϰí ÇÕº´ÁõÀ» ÃÖ¼ÒÈ­Çϱâ À§ÇØ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. ¼º°øÀûÀÎ ÀçȰÀ» À§Çؼ­´Â ºÎÁ¾°ú ºÒÆí°¨ ¸ð´ÏÅ͸µÀ» Æ÷ÇÔÇÑ ÈÄ¼Ó Ä¡·á°¡ ÇʼöÀûÀÔ´Ï´Ù.

¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é, Àεµ´Â Àü ¼¼°è ±³Åë»ç°í »ç¸ÁÀÚÀÇ 11%¸¦ Â÷ÁöÇϰí ÀÖÀ¸¸ç, ±³Åë»ç°í·Î ÀÎÇÑ ºÎ»óÀº Àεµ¿¡¼­ 8¹øÂ°·Î ³ôÀº »ç¸Á¿øÀÎÀ» Â÷ÁöÇϰí ÀÖ½À´Ï´Ù.

°ñÀý ¹× °üÀý ¼Õ»óÀÇ Áõ°¡

ºÎ»óÀÚ ¼ö°¡ Áõ°¡ÇÔ¿¡ µû¶ó º¸´Ù °í±Þ½º·´°í Àü¹®ÀûÀÎ ±é½º ¹× ºÎ¸ñ Àç·á¿¡ ´ëÇÑ ¿ä±¸°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ´Â ½ÃÀåÀÇ Çõ½ÅÀ» ÃËÁøÇÏ¿© ȯÀÚÀÇ Æí¾ÈÇÔÀ» Çâ»ó½ÃŰ´Â °¡º±°í Æí¾ÈÇÑ ¼ÒÀç, Ä¡À¯ Áß À§»ý°ú ±â´É¼ºÀ» Çâ»ó½ÃŰ´Â ¹æ¼ö ¼®°í, ¿òÁ÷ÀÓ Á¦¾î ¹× ÀçȰÀ» °¡´ÉÇÏ°Ô ÇÏ´Â Á¶Àý °¡´ÉÇÑ ºÎ¸ñ°ú °°Àº »õ·Î¿î Á¦Ç°À» °³¹ßÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÀÌó·³ ºÎ»óÀÇ ¹üÀ§°¡ ³Ð¾îÁü¿¡ µû¶ó ƯÁ¤ ¿ä±¸»çÇ׿¡ ´ëÇÑ ´ëÀÀÀÌ ¿ä±¸µÇ°í ÀÖ½À´Ï´Ù. µû¶ó¼­ ¼Õ¸ñ, ¹ß¸ñ ¶Ç´Â ƯÁ¤ °íÁ¤ ±â¼úÀÌ ÇÊ¿äÇÑ º¹ÀâÇÑ °ñÀý¿¡ ƯȭµÈ ºÎ¸ñÀÌ °³¹ßµÇ±âµµ ÇÕ´Ï´Ù.

³ôÀº ºñ¿ë

³ôÀº ºñ¿ëÀ¸·Î ÀÎÇØ °¡´ÉÇÑ ÇÑ ±é½º ¹× ºÎ¸ñ¿¡ ´ëÇÑ ºñ¿ë È¿À²ÀûÀÎ ´ë¾ÈÀ» ã´Â µ¥ ÁßÁ¡À» µÑ ¼ö ÀÖ½À´Ï´Ù. µû¶ó¼­ ºÎ¸ñÀ» ÇÊ¿ä·Î ÇÏÁö ¾Ê´Â º¸Á¶±â³ª ¹°¸®Ä¡·á ±â¹ýÀÇ »ç¿ëÀÌ Áõ°¡ÇÏ¿© ±é½º ¹× ºÎ¸ñ Á¦Ç°ÀÇ ½ÃÀå ±Ô¸ð°¡ Àü¹ÝÀûÀ¸·Î Ãà¼ÒµÉ ¼ö ÀÖ½À´Ï´Ù. ÀÌ´Â ¾ÈÀü¼º¿¡ ´ëÇÑ ¿ì·Á¸¦ ºÒ·¯ÀÏÀ¸Å°°í Çõ½ÅÀûÀÎ ½Å¼ÒÀç °³¹ßÀ» ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.

³ë·ÉÀα¸ÀÇ Áõ°¡

³ë³âÃþÀÌ µÇ¸é »À°¡ ¾àÇØÁ® ÀÛÀº ³«»ó¿¡µµ ½±°Ô °ñÀýµÇ´Â °ñ´Ù°øÁõ¿¡ °É¸®±â ½±½À´Ï´Ù. µû¶ó¼­ °ñÀýÀÌ Ä¡À¯µÇ´Â µ¿¾È °ñÀýÀ» °íÁ¤Çϰí ÁöÁöÇϱâ À§ÇÑ ±é½º³ª ºÎ¸ñÀÇ Çʿ伺ÀÌ ÇöÀúÇÏ°Ô Áõ°¡ÇÕ´Ï´Ù. ³ëÈ­¿¡ µû¸¥ ±ÕÇü°ú ÇùÀÀ·Â °¨¼Ò´Â ƯÈ÷ ³ë³âÃþÀÇ ³«»ó ¹× ºÎ»ó ºóµµ¸¦ Áõ°¡½Ãŵ´Ï´Ù. ÀÌ·¯ÇÑ ³«»óÀº Ç㸮, ¼Õ¸ñ, ¹ß¸ñ °ñÀýÀÇ ¿øÀÎÀÌ µÉ ¼ö ÀÖÀ¸¸ç, ÀûÀýÇÑ Ä¡À¯¸¦ À§ÇØ ±é½º³ª ºÎ¸ñÀÌ ÇÊ¿äÇÕ´Ï´Ù.

ÇÕº´ÁõÀÇ À§Ç輺

°¨¿°À̳ª ºÎÀûÀýÇÑ Ä¡À¯¿Í °°Àº ÇÕº´ÁõÀ¸·Î ÀÎÇØ Ãß°¡ Ä¡·á°¡ ÇÊ¿äÇÑ °æ¿ì, ÀÇ·á ºñ¿ëÀÌ Å©°Ô Áõ°¡ÇÕ´Ï´Ù. ÀÌ´Â ÀÇ·á ¿¹»êÀ» ¾Ð¹ÚÇÏ°í Æ¯Á¤ »óȲ¿¡¼­ ±é½º ¹× ºÎ¸ñ »ç¿ë¿¡ ´ëÇÑ ±ÔÁ¦¿Í Á¦ÇÑÀ» °­È­ÇÒ ¼ö ÀÖ½À´Ï´Ù. ±× °á°ú ÀÇ·á °ú½Ç º¸Çè ºñ¿ëÀÌ Áõ°¡ÇÏ¿© ÀÇ·á ¼­ºñ½º Á¦°øÀÚ°¡ ±é½º ¹× ºÎ¸ñ »ç¿ë¿¡ ½ÅÁßÀ» ±âÇÏ°í ±× Àû¿ëÀÌ Á¦ÇÑµÉ ¼ö ÀÖ½À´Ï´Ù.

COVID-19ÀÇ ¿µÇâ

COVID-19 »çÅ´ ÀεµÀû, °æÁ¦Àû À§±â·Î ºÎ»óÇÏ¿© »çȸ¸¦ µÚÈçµé°í ¼ö¹é¸¸ ¸íÀÇ »ç¶÷µé°ú ±â¾÷¿¡ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù. »ê¾÷Àº Æó¼âµÇ°í »ç¶÷µéÀº Áý¿¡¼­ »ýÈ°ÇØ¾ß Çϸç, ±× °á°ú Àڱݰú °æÁ¦ ¼ºÀå¿¡ Å« Ÿ°ÝÀ» ÀÔ¾ú½À´Ï´Ù. ÀÇ·á ±â°üÀº ÀÌ¹Ì ÀüÅõ ż¼¿¡ µ¹ÀÔÇÏ¿© ½Å¼Ó Áø´Ü ŰƮ Á¶´Þ¿¡¼­ ÀÛ¾÷ÀÚ¸¦ À§ÇÑ ÃæºÐÇÑ PPE ŰƮ¿¡ À̸£±â±îÁö Áõ°¡ÇÏ´Â COVID-19 ȯÀÚ¸¦ ¼ö¿ëÇϱâ À§ÇÑ »õ·Î¿î °èȹÀ» ÁغñÇϰí ÀÖ½À´Ï´Ù. ÀÇ·á ºÐ¾ß°¡ COVID-19 Ä¡·á¿¡ ÁýÁߵǸ鼭 ±é½º ¹× ºÎ¸ñ °ü·Ã ¿¬±¸ ¹× °³¹ß Ȱµ¿¿¡ ´ëÇÑ ÀÚ±ÝÀÌ °¨¼ÒÇÏ¿© ÀÌ ºÐ¾ß´Â ºÎÁÖÀÇ¿¡ Á÷¸éÇÏ°Ô µÇ¾ú°í, ±× °á°ú ±é½º ¹× ºÎ¸ñ ½ÃÀå¿¡ ºÎÁ¤ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡°í ÀÖ½À´Ï´Ù.

ºÎ¸ñ ºÐ¾ß´Â ¿¹Ãø ±â°£ µ¿¾È ÃÖ´ë ±Ô¸ð°¡ µÉ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

ºÎ¸ñÀº °æ¼º ¼®°í¿¡ ºñÇØ ´ÙÀç´Ù´ÉÇϱ⠶§¹®¿¡ ºÎ¸ñ ºÐ¾ß´Â À¯¸®ÇÑ ¼ºÀåÀ» ÇÒ °ÍÀ¸·Î ÃßÁ¤µË´Ï´Ù. ºÎ¸ñÀº ºÎÁ¾¿¡ ´ëÀÀÇϰųª Ä¡À¯ Áß ¿òÁ÷ÀÓÀ» Á¦¾îÇÒ ¼ö ÀÖµµ·Ï Á¶Á¤ÇÒ ¼ö Àֱ⠶§¹®¿¡ ´õ ±¤¹üÀ§ÇÑ ±Ù°ñ°Ý°è ºÎ»ó¿¡ ÀûÇÕÇÕ´Ï´Ù. µû¶ó¼­ ±é½º¸¦ ÅëÇÑ ¿ÏÀüÇÑ °íÁ¤ÀÌ ÇÊ¿äÇÑ ºÎ»ó À̿ܿ¡µµ ´ëÀÀÇÒ ¼ö ÀÖ¾î ½ÃÀåÀÇ ÆøÀ» ³ÐÈú ¼ö ÀÖ½À´Ï´Ù.

¿¹Ãø ±â°£ µ¿¾È °¡Àå ³ôÀº CAGRÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµÇ´Â ºÐ¾ß´Â ±Ù°ñ°Ý°è ¼Õ»ó ºÐ¾ßÀÔ´Ï´Ù.

°ñÀý, ¿°ÁÂ, ¿°ÁÂ, º¯Çü, Å»±¸ µî ±Ù°ñ°Ý°è ¼Õ»óÀº ±é½º³ª ºÎ¸ñÀÌ ÇÊ¿äÇÑ ÁÖ¿ä ÀÌÀ¯ÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ºÎ»óÀÇ ³ôÀº ¹ß»ý·üÀº ±é½º ¹× ºÎ¸ñÀÌ Á¦°øÇÏ´Â °íÁ¤ ¹× ÁöÁö·Â¿¡ ´ëÇÑ ³ôÀº Çʿ伺°ú Á÷°áµË´Ï´Ù. ÀÌ·¯ÇÑ ¼ö¿ä Áõ°¡´Â ±é½º ¹× ºÎ¸ñ ½ÃÀå Á¦Á¶¾÷ü¿Í °ø±Þ¾÷üÀÇ ¸ÅÃâ°ú ¼öÀÍÀ» Áõ°¡½Ã۰í ÀÖ½À´Ï´Ù.

°¡Àå Å« Á¡À¯À²À» Â÷ÁöÇÏ´Â Áö¿ª:

¾Æ½Ã¾ÆÅÂÆò¾çÀº ¿¹Ãø ±â°£ µ¿¾È °¡Àå Å« ½ÃÀå Á¡À¯À²À» Â÷ÁöÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÀÌ´Â Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡, ÀÀ±Þ »óȲ ¹× ±³Åë »ç°í »ç·Ê Áõ°¡, ½É°¢ÇÑ ±Ù°ñ°Ý°è ºÎ»óÀ¸·Î À̾îÁö´Â ¸ðÇè ¹× ½ºÆ÷Ã÷ Ȱµ¿ Áõ°¡, ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ±â¼ú äÅ÷ü Áõ°¡ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ ¾Æ½Ã¾ÆÅÂÆò¾çÀÇ ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, Àεµ, ÀϺ», Áß±¹, Çѱ¹ µî Àα¸ ¹Ðµµ°¡ ³ô°í ±³Åë»ç°í ¹× Á¤Çü¿Ü°úÀû ¼Õ»ó »ç·Ê°¡ ¸¹Àº ±¹°¡µéÀÇ Á¸Àç´Â ±é½º ºØ´ë ¹× ºÎ¸ñ µµ±¸ ½ÃÀåÀÇ ¼ö¿ä¸¦ Áõ°¡½ÃŰ´Â °á°ú¸¦ ³º°í ÀÖ½À´Ï´Ù.

CAGRÀÌ °¡Àå ³ôÀº Áö¿ª:

ºÏ¹Ì´Â Á¦Á¶ ½Ã¼³ÀÇ ¼ö°¡ ¸¹°í Àú·ÅÇÑ ³ëµ¿·ÂÀ» ÀÌ¿ëÇÒ ¼ö Àֱ⠶§¹®¿¡ ÀÌ·¯ÇÑ ÀåºñÀÇ Á¦Á¶ ºñ¿ëÀ» ³·°Ô À¯ÁöÇÏ¿© ¾÷°èÀÇ ¿ä±¸ »çÇ×À» ÃæÁ·Çϱâ À§ÇØ Àú·ÅÇÑ Àåºñ¸¦ ´ë·®À¸·Î Á¦°øÇÏ´Â µ¥ µµ¿òÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. Àú·ÅÇÑ ºñ¿ëÀ¸·Î ´õ ³ªÀº °Ç°­ °á°ú¸¦ ¾òÀ¸·Á´Â ³ôÀº ±äÀå°¨°ú Àα¸ ¹ÐÁý Áö¿ªÀÌ °¡±î¿î ¹Ì·¡¿¡ ½ÃÀåÀ» ÃËÁøÇÏ´Â ¶Ç ´Ù¸¥ ¿äÀÎÀÔ´Ï´Ù.

¹«·á ¸ÂÃãÇü ¼­ºñ½º:

ÀÌ º¸°í¼­¸¦ ±¸µ¶ÇÏ´Â °í°´Àº ´ÙÀ½°ú °°Àº ¹«·á ¸ÂÃãÈ­ ¿É¼Ç Áß Çϳª¸¦ »ç¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù.

  • ±â¾÷ °³¿ä
    • Ãß°¡ ½ÃÀå ±â¾÷ÀÇ Á¾ÇÕÀûÀÎ ÇÁ·ÎÆÄÀϸµ(ÃÖ´ë 3°³»ç±îÁö)
    • ÁÖ¿ä ±â¾÷ SWOT ºÐ¼®(ÃÖ´ë 3°³»ç)
  • Áö¿ª ¼¼ºÐÈ­
    • °í°´ÀÇ °ü½É¿¡ µû¸¥ ÁÖ¿ä ±¹°¡º° ½ÃÀå ÃßÁ¤Ä¡, ¿¹Ãø, CAGR(ÁÖ: Ÿ´ç¼º °ËÅä¿¡ µû¸¥)
  • °æÀï»ç º¥Ä¡¸¶Å·
    • Á¦Ç° Æ÷Æ®Æú¸®¿À, Áö¸®Àû ÀÔÁö, Àü·«Àû Á¦ÈÞ¸¦ ±â¹ÝÀ¸·Î ÇÑ ÁÖ¿ä ±â¾÷ º¥Ä¡¸¶Å·

¸ñÂ÷

Á¦1Àå ÁÖ¿ä ¿ä¾à

Á¦2Àå ¼­¹®

  • °³¿ä
  • ÀÌÇØ°ü°èÀÚ
  • Á¶»ç ¹üÀ§
  • Á¶»ç ¹æ¹ý
    • µ¥ÀÌÅÍ ¸¶ÀÌ´×
    • µ¥ÀÌÅÍ ºÐ¼®
    • µ¥ÀÌÅÍ °ËÁõ
    • Á¶»ç Á¢±Ù¹ý
  • Á¶»ç Á¤º¸ Ãâó
    • 1Â÷ Á¶»ç Á¤º¸ Ãâó
    • 2Â÷ Á¶»ç Á¤º¸ Ãâó
    • °¡Á¤

Á¦3Àå ½ÃÀå µ¿Ç⠺м®

  • ¼ºÀå ÃËÁø¿äÀÎ
  • ¼ºÀå ¾ïÁ¦¿äÀÎ
  • ±âȸ
  • À§Çù
  • Á¦Ç° ºÐ¼®
  • ¿ëµµ ºÐ¼®
  • ÃÖÁ¾»ç¿ëÀÚ ºÐ¼®
  • ½ÅÈï ½ÃÀå
  • COVID-19ÀÇ ¿µÇâ

Á¦4Àå Porter's Five Forces ºÐ¼®

  • °ø±Þ ±â¾÷ÀÇ ±³¼··Â
  • ±¸¸ÅÀÚÀÇ ±³¼··Â
  • ´ëüǰÀÇ À§Çù
  • ½Å±Ô Âü¿©¾÷üÀÇ À§Çù
  • °æÀï ±â¾÷ °£ÀÇ °æÀï °ü°è

Á¦5Àå ¼¼°èÀÇ ¼®°í ¹× ºÎ¸ñ ½ÃÀå : Á¦Ç° À¯Çüº°

  • ¼®°í
    • ÆÄÀ̹ö±Û¶ó½º ¼®°í
    • Çöó½ºÅÍ ¼®°í
    • Æú¸®¿ì·¹Åº ¼®°í
    • ±âŸ ¼®°í Á¦Ç°
  • ºÎ¸ñ
    • ÆÄÀ̹ö±Û¶ó½º ºÎ¸ñ
    • Çöó½ºÅÍ ºÎ¸ñ
    • ±âŸ ºÎ¸ñ Á¦Ç°

Á¦6Àå ¼¼°èÀÇ ¼®°í ¹× ºÎ¸ñ ½ÃÀå : ¿ëµµº°

  • °ñÀý °ü¸®
    • »óÁö
    • ÇÏÁö
  • ±Ù°ñ°Ý°è ¼Õ»ó
    • ¼ö±Ù°üÁõÈıº
    • ¿°ÁÂ
    • °Ç Àå¾Ö
    • ±âŸ ±Ù°ñ°Ý°è ¼Õ»ó

Á¦7Àå ¼¼°èÀÇ ¼®°í ¹× ºÎ¸ñ ½ÃÀå : ÃÖÁ¾»ç¿ëÀÚº°

  • º´¿ø
  • Ŭ¸®´Ð
  • ÀçÅà ÇコÄɾî
  • ¿Ü·¡ ¼ö¼ú ¼¾ÅÍ

Á¦8Àå ¼¼°èÀÇ ¼®°í ¹× ºÎ¸ñ ½ÃÀå : Áö¿ªº°

  • ºÏ¹Ì
    • ¹Ì±¹
    • ij³ª´Ù
    • ¸ß½ÃÄÚ
  • À¯·´
    • µ¶ÀÏ
    • ¿µ±¹
    • ÀÌÅ»¸®¾Æ
    • ÇÁ¶û½º
    • ½ºÆäÀÎ
    • ±âŸ À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
    • ÀϺ»
    • Áß±¹
    • Àεµ
    • È£ÁÖ
    • ´ºÁú·£µå
    • Çѱ¹
    • ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
  • ³²¹Ì
    • ¾Æ¸£ÇîÆ¼³ª
    • ºê¶óÁú
    • Ä¥·¹
    • ±âŸ ³²¹Ì
  • Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
    • »ç¿ìµð¾Æ¶óºñ¾Æ
    • ¾Æ¶ø¿¡¹Ì¸®Æ®
    • īŸ¸£
    • ³²¾ÆÇÁ¸®Ä«°øÈ­±¹
    • ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«

Á¦9Àå ÁÖ¿ä ¹ßÀü

  • °è¾à, ÆÄÆ®³Ê½Ê, Çù¾÷, ÇÕÀÛÅõÀÚ
  • Àμö¿Í ÇÕº´
  • ½ÅÁ¦Ç° ¹ß¸Å
  • »ç¾÷ È®´ë
  • ±âŸ ÁÖ¿ä Àü·«

Á¦10Àå ±â¾÷ °³¿ä

  • 3M Company
  • Alimed, Inc.
  • Ascent Meditech Limited
  • B. Braun Melsungen AG
  • Bird & Cronin, Inc.
  • BSN medical GmbH
  • Corflex, Inc.
  • DeRoyal Industries, Inc.
  • DJO Global, Inc.
  • Medtronic plc
  • Orfit Industries NV
  • Ossur hf.
  • Ottobock SE & Co. KGaA
  • Patterson Medical Holdings, Inc.
  • Prime Medical, Inc.
  • Remington Products
  • Smith & Nephew plc
  • Spencer Italia S.r.l.
  • Stryker Corporation
  • Zimmer Biomet Holdings, Inc.
ksm 24.05.23

According to Stratistics MRC, the Global Casting and Splinting Market is accounted for $2.8 billion in 2023 and is expected to reach $5.1 billion by 2030 growing at a CAGR of 8.7% during the forecast period. Casting and splinting are orthopedic techniques used to immobilize and support injured bones and soft tissues. A cast is typically made from fiberglass or plaster and encases the injured area completely, providing rigid stabilization. Splints, made from materials like metal or fiberglass, offer more flexibility and are often used for temporary support or minor fractures. Both methods aim to promote healing, reduce pain, and prevent further injury by restricting movement. Proper application by trained professionals is crucial to ensure effectiveness and minimize complications. Follow-up care, including monitoring for swelling and discomfort, is essential for successful rehabilitation.

According to the World Health Organization, India accounts for 11% of the global road accident deaths, and road traffic injuries are the eighth leading cause of death in India.

Market Dynamics:

Driver:

Rising incidence of bone fractures and joint injuries

As the number of injuries rise, there's a growing need for more advanced and specialized casting and splinting materials. This spurs innovation in the market, leading to the development of new products like lighter and more comfortable materials for improved patient experience, water-resistant casts for better hygiene and functionality during healing, Adjustable splints that allow for controlled movement and rehabilitation. Thus With a wider range of injuries, there's a demand for catering to specific needs. This can lead to the development of specialized splints for wrists, ankles, or even for complex fractures requiring specific immobilization techniques.

Restraint:

High cost

Due to the high costs, there might be a greater emphasis on finding cost-effective alternatives to casting and splinting whenever possible. This could lead to increased use of braces or physical therapy techniques that might not require splinting, potentially reducing the overall market size for casting and splinting products. This could result in safety concerns or hinder the development of innovative new splinting materials.

Opportunity:

Growing geriatric population

As people age, they become more susceptible to osteoporosis, a condition that weakens bones and makes them more prone to fractures even from minor falls. This significantly increases the need for casting and splinting to immobilize and support fractures during healing. Age-related decline in balance and coordination can lead to more frequent falls and injuries, especially among the elderly. These falls can cause bone fractures in the hips, wrists, and ankles, all requiring casting or splinting for proper healing.

Threat:

Risk of complications

Complications like infections or improper healing that necessitate additional treatment can significantly increase healthcare costs. This puts a strain on healthcare budgets and can lead to stricter regulations or limitations on the use of casting and splinting in certain situations. This can increase malpractice insurance costs and make healthcare providers more cautious in using casting and splinting, potentially limiting its application.

Covid-19 Impact

The COVID-19 pandemic has emerged as a humanitarian as well as economic crisis, creating strain on the society and affecting millions of people and businesses. Industry closures and people are asked to stay in their homes which have cause taken a huge toll in terms of money and economic growth. Healthcare organizations are already working in battle mode, preparing new plans to respond growing COVID-19 patients, right from sourcing rapid diagnosing kits to sufficient PPE kits for workers. Due to diversion of medical field towards treating COVID-19, the funding to R&D activities related to casting and splinting has been reduced and this segment have to face negligence subsequently causing negative impact on casting and splinting market.

The splinting segment is expected to be the largest during the forecast period

The splinting segment is estimated to have a lucrative growth, as splints offer more versatility compared to rigid casts. They can be adjusted to accommodate swelling or allow for controlled movement during healing, making them suitable for a wider range of musculoskeletal injuries. This expands the market reach by catering to injuries beyond those requiring complete immobilization with a cast.

The musculoskeletal injuries segment is expected to have the highest CAGR during the forecast period

The musculoskeletal injuries segment is anticipated to witness the highest CAGR growth during the forecast period, musculoskeletal injuries, including bone fractures, sprains, strains, and dislocations, are a major reason why casting and splinting are needed. A higher incidence of these injuries directly translates to a greater need for immobilization and support, which is what casts and splints provide. This increased demand fuels sales and revenue for manufacturers and suppliers in the casting and splinting market.

Region with largest share:

Asia Pacific is projected to hold the largest market share during the forecast period due to factors like rise in the global prevalence of geriatric populace, rising cases of emergencies and road accidents, growth in adventures and sports activities leading to severe musculoskeletal injuries and higher adoption of technology in the region is propelling the market in the Asia-Pacific segment. Additionally presence of densely populated states including India, Japan, China, and Korea having large number of cases of road accidents as well as orthopedic injuries that will result in boosting the demand for casting and splinting equipment market

Region with highest CAGR:

North America is projected to have the highest CAGR over the forecast period, owing to the high number of manufacturing facilities, availability of cheap labor helps to keep the manufacturing costs for these equipment low, which will help in providing affordable equipment in bulk quantities to meet the industry requirement. High strain to get better health outputs at lower costs and dense population base are the other factors fuelling the market in the near future.

Key players in the market

Some of the key players in the Casting and Splinting Market include 3M Company, Alimed, Inc., Ascent Meditech Limited, B. Braun Melsungen AG, Bird & Cronin, Inc., BSN medical GmbH, Corflex, Inc., DeRoyal Industries, Inc., DJO Global, Inc., Medtronic plc, Orfit Industries NV, Ossur hf., Ottobock SE & Co. KGaA, Patterson Medical Holdings, Inc., Prime Medical, Inc., Remington Products, Smith & Nephew plc, Spencer Italia S.r.l., Stryker Corporation and Zimmer Biomet Holdings, Inc.

Key Developments:

In April 2024, Smith+Nephew announces new evidence supporting ALLEVYN* LIFE Foam Dressing's role in pressure injury prevention. This novel mechanism of action further adds to our understanding of how multi-layer dressings such as ALLEVYN LIFE work when used prophylactically for PIP.1

In April 2024, 3M launches new Verify app to help tackle counterfeit personal protective equipment. Depending on the type of product, using a counterfeit product could put a person's safety at risk.

In March 2024, 3M introduces a world's first innovation to help redefine shipping and packaging. This new material called 3M(TM) Padded Automatable Curbside Recyclable (PACR) Mailer Material is capable of producing packages up to three times faster than manual packing

Product Types Covered:

  • Casting
  • Splinting

Applications Covered:

  • Fracture Management
  • Musculoskeletal Injuries

End Users Covered:

  • Hospitals
  • Clinics
  • Home Healthcare
  • Ambulatory Surgical Centers

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 Product Analysis
  • 3.7 Application Analysis
  • 3.8 End User Analysis
  • 3.9 Emerging Markets
  • 3.10 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Casting and Splinting Market, By Product Type

  • 5.1 Introduction
  • 5.2 Casting
    • 5.2.1 Fiberglass Casts
    • 5.2.2 Plaster Casts
    • 5.2.3 Polyurethane Casts
    • 5.2.4 Other Casting Products
  • 5.3 Splinting
    • 5.3.1 Fiberglass Splints
    • 5.3.2 Plaster Splints
    • 5.3.3 Other Splinting Products

6 Global Casting and Splinting Market, By Application

  • 6.1 Introduction
  • 6.2 Fracture Management
    • 6.2.1 Upper Extremities
    • 6.2.2 Lower Extremities
  • 6.3 Musculoskeletal Injuries
    • 6.3.1 Carpal Tunnel Syndrome
    • 6.3.2 Sprains
    • 6.3.3 Tendinopathy
    • 6.3.4 Other Musculoskeletal Injuries

7 Global Casting and Splinting Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.4 Home Healthcare
  • 7.5 Ambulatory Surgical Centers

8 Global Casting and Splinting Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 3M Company
  • 10.2 Alimed, Inc.
  • 10.3 Ascent Meditech Limited
  • 10.4 B. Braun Melsungen AG
  • 10.5 Bird & Cronin, Inc.
  • 10.6 BSN medical GmbH
  • 10.7 Corflex, Inc.
  • 10.8 DeRoyal Industries, Inc.
  • 10.9 DJO Global, Inc.
  • 10.10 Medtronic plc
  • 10.11 Orfit Industries NV
  • 10.12 Ossur hf.
  • 10.13 Ottobock SE & Co. KGaA
  • 10.14 Patterson Medical Holdings, Inc.
  • 10.15 Prime Medical, Inc.
  • 10.16 Remington Products
  • 10.17 Smith & Nephew plc
  • 10.18 Spencer Italia S.r.l.
  • 10.19 Stryker Corporation
  • 10.20 Zimmer Biomet Holdings, Inc.
»ùÇà ¿äû ¸ñ·Ï
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
¸ñ·Ï º¸±â
Àüü»èÁ¦